Petros Pharmaceuticals, Inc.
SEC CIK 1815903 · PTPI · last insider filing 2026-06-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Walker Wayne Remell | Director | filed 2020 - 2026 |
| Silverman Joshua | Director | filed 2020 - 2026 |
| Bernstein Bruce | Director | filed 2020 - 2026 |
| Bradley Greg | Director | filed 2020 - 2023 |
| Shulman John D | Director | filed 2020 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Weinstein Robert | Chief Accounting Officer | filed 2026 - 2026 |
| Boctor Fady | See Remarks | filed 2020 - 2026 |
| Arnold Mitchell | See Remarks | filed 2021 - 2025 |
| Gesek Andrew | President, Timm Medical | filed 2020 - 2021 |
| Lavan Keith | Chief Financial Officer | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.